Engineered for Precision. Built for Clinical Relevance.
Engineered for Precision.
Built for Clinical Relevance.
Borrelia, Babesia and Bartonella are stealth pathogens, low-abundance, slow-replicating organisms that suppress immune response and evade detection. Although lab-developed testing has improved, most diagnostics still rely on indirect markers, missing the root of the problem.
We do things differently— because precision demands it.
Using science-backed, proprietary methods to directly detect these elusive pathogens with industry-leading sensitivity.
Built for Clinical Confidence
Every assay we use is optimized in-house and rigorously validated by our team of scientists to ensure clinical relevance, so providers get actionable results even when other tests fall short.
Urine Antigen Detection - Nanotrap®
Nanotrap® technology captures and concentrates Borrelia antigens directly from urine, dramatically increasing sensitivity, especially in early-stage Lyme and complex chronic cases. Unlike antibody tests, it detects the pathogen itself, not the body’s immune response.
- Enables direct detection of Lyme Borrelia antigens
- Ideal for early detection and persistent symptoms
- Manufactured by Ceres Nanosciences
Digital PCR (dPCR) for Stealth Pathogens
Galaxy's Digital PCR breaks samples into thousands of partitions, detecting trace amounts of pathogen DNA that other technologies miss. Originally pioneered in oncology, now adapted for infectious disease.
- Complete a 3-day blood draw, which increases the probability of low abundance pathogens
- 6x higher positivity rates in high-risk patients
- Identifies infections at low microbial load
- Backed by SBIR-funded research and peer-reviewed studies
Bartonella IFA Serology (4-Species Panel)
The most comprehensive Bartonella IgG IFA panel available, targeting the four species most associated with human disease, built using clinical isolates, not commercial slides and reported as titers.
- Detects exposure to B. henselae, B. vinsonii berkhoffii, B. quintana, and B. koehlerae
- Pioneered by NC State's Bartonella research team
- Backed by peer-reviewed studies
Designed for Real-World Clinical Use
Detects current presence of infection
Get the direct evidence needed to guide next steps, not just past exposure.
Improves early-stage detection
Helps you catch infections others miss, before they become harder to treat.
Backed by peer-reviewed science
Vetted by published data, not just internal claims.
Built for clarity, not complexity
You shouldn’t need a specialist to interpret your results, though we’re here if you need us.